669 related articles for article (PubMed ID: 19716383)
1. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
Kumar P; Kumar A
Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine A attenuates 3-nitropropionic acid-induced Huntington-like symptoms in rats: possible nitric oxide mechanism.
Kumar P; Kalonia H; Kumar A
Int J Toxicol; 2010; 29(3):318-25. PubMed ID: 20448265
[TBL] [Abstract][Full Text] [Related]
4. Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study.
Kumar P; Kalonia H; Kumar A
J Psychopharmacol; 2011 Oct; 25(10):1399-411. PubMed ID: 20305041
[TBL] [Abstract][Full Text] [Related]
5. Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity.
Kumar P; Kalonia H; Kumar A
Life Sci; 2009 Nov; 85(19-20):711-8. PubMed ID: 19822156
[TBL] [Abstract][Full Text] [Related]
6. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
[TBL] [Abstract][Full Text] [Related]
7. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain.
Kumar P; Kumar A
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):100-8. PubMed ID: 19022325
[TBL] [Abstract][Full Text] [Related]
8. Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity.
Kumar P; Kalonia H; Kumar A
Eur J Pharmacol; 2012 Jan; 674(2-3):265-74. PubMed ID: 22154757
[TBL] [Abstract][Full Text] [Related]
9. Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats.
Menze ET; Tadros MG; Abdel-Tawab AM; Khalifa AE
Neurotoxicology; 2012 Oct; 33(5):1265-75. PubMed ID: 22850463
[TBL] [Abstract][Full Text] [Related]
10. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Dhir A; Akula KK; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum.
Thangarajan S; Deivasigamani A; Natarajan SS; Krishnan P; Mohanan SK
Int J Neurosci; 2014 Sep; 124(9):673-84. PubMed ID: 24325390
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide mechanism in the protective effect of naringin against post-stroke depression (PSD) in mice.
Aggarwal A; Gaur V; Kumar A
Life Sci; 2010 Jun; 86(25-26):928-35. PubMed ID: 20433854
[TBL] [Abstract][Full Text] [Related]
13. N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease.
Sandhir R; Sood A; Mehrotra A; Kamboj SS
Neurodegener Dis; 2012; 9(3):145-57. PubMed ID: 22327485
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
Tariq M; Khan HA; Elfaki I; Al Deeb S; Al Moutaery K
Brain Res Bull; 2005 Sep; 67(1-2):161-8. PubMed ID: 16140176
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
Kalonia H; Kumar P; Kumar A
Pharmacol Biochem Behav; 2010 Aug; 96(2):115-24. PubMed ID: 20450929
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease.
Pandey M; Varghese M; Sindhu KM; Sreetama S; Navneet AK; Mohanakumar KP; Usha R
J Neurochem; 2008 Jan; 104(2):420-34. PubMed ID: 17953654
[TBL] [Abstract][Full Text] [Related]
17. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
Kumar P; Kumar A
J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
Bhateja DK; Dhull DK; Gill A; Sidhu A; Sharma S; Reddy BV; Padi SS
Eur J Pharmacol; 2012 Jan; 674(1):33-43. PubMed ID: 22056833
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype.
Tadros MG; Khalifa AE; Abdel-Naim AB; Arafa HM
Pharmacol Biochem Behav; 2005 Nov; 82(3):574-82. PubMed ID: 16337998
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis.
Gopinath K; Prakash D; Sudhandiran G
Neurochem Int; 2011 Dec; 59(7):1066-73. PubMed ID: 21945202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
